Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe
Mandate

Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe

November 25, 2021 M&A Banking and Finance

Vinge has advised Formica Capital in connection with its acquisition of all shares in the Rototec Group. Rototec is a market leader in the field of geoenergy solutions for medium and large sized properties and handles Europe’s largest fleet of drilling equipment for geoenergy issues in Finland, Sweden and Norway.

Vinge’s team mainly consisted of Magnus Pauli (M&A), Johanna Hamrefält (Project Manager, M&A), Alexander Lindeberg (IP), Adam Loewenstein (M&A), Malin Olsson (HR), Hanna Marberg (M&A) as well as Fabian Ekeblad (Banking & Finance) and Elin Samara (Banking & Finance). Krogerus Attorneys acted as local counsel in Finland with Advokatfirmaet Thommessen AS acting as local counsel in Norway.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026